Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) FCF Margin (2016 - 2025)

Mimedx (MDXG) has disclosed FCF Margin for 15 consecutive years, with 20.89% as the latest value for Q4 2025.

  • Quarterly FCF Margin fell 4.0% to 20.89% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 17.43% through Dec 2025, down 133.0% year-over-year, with the annual reading at 17.43% for FY2025, 133.0% down from the prior year.
  • FCF Margin hit 20.89% in Q4 2025 for Mimedx, down from 25.62% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 25.62% in Q3 2025 to a low of 17.56% in Q1 2022.
  • Historically, FCF Margin has averaged 7.66% across 5 years, with a median of 5.84% in 2023.
  • Biggest five-year swings in FCF Margin: skyrocketed 1942bps in 2023 and later tumbled -1045bps in 2025.
  • Year by year, FCF Margin stood at 7.0% in 2021, then soared by 170bps to 4.88% in 2022, then soared by 288bps to 18.92% in 2023, then rose by 11bps to 20.93% in 2024, then decreased by 0bps to 20.89% in 2025.
  • Business Quant data shows FCF Margin for MDXG at 20.89% in Q4 2025, 25.62% in Q3 2025, and 14.44% in Q2 2025.